I think the FDA is waiting to see Phase 2 M2M data before
I think the FDA is waiting to see Phase 2 M2M data before making a decision of when to look at Phase 3 data. If it's good or better, they perform interim analysis right away, which will provide them with a number bigger than 50 to make a decision. They can then more confidently ("rolls eyes" ) make the call to issue an Emergency Use Approval with a n > 50. Especially since they know we have 120 enrolled.
This is the difference of 1-3 weeks maybe. It's unfortunate because more people will die who could have potentially been saved. However, it also provides greater assurance that the true power of Leronlimab will be displayed in the P3 interim data.
Makes sense, do it right (your idea of "right" may vary from the FDA's), do it the first time. I believe the FDA is on our side, just not our timeline. They work in a super conservative manner with their blinders on to outside noise aka non-placebo controlled data.
I have also come to think that once this is all said and done, and Leronlimab saves many people from several grievous illnesses, that there will be a look back into why this was not given to the world sooner. Or one can at least hope.
I've waited for news and updates for almost 2 years at this point, now more anxiously than ever. But what's another few weeks. Long and Strong.
5
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Sun Life Financial Inc. Announces Q3 2025 Dividends Today, the Board of Directors of Sun Life Financial Inc. (TSX: SLF, NYSE: SLF) declared a dividend of $0.88 per share on the common shares, marking a continuation of the same amount paid in the previous quarter. This upcoming dividend is set for payment on September 29, 2025, to shareholders of record at the close of...
Continue Reading
Spartan Capital Securities' Successful Involvement in Safe Pro Group's IPO Spartan Capital Securities LLC, a leading investment banking firm, has successfully co-managed the initial public offering (IPO) for Safe Pro Group Inc. This collaboration has led to a remarkable fundraising achievement, bringing in a total of $5.1 million through the sale of 1,020,000 shares of...
Continue Reading
Stagwell Introduces the News Network for Enhanced Advertising The newly launched Stagwell News Network marks a significant milestone in media marketing, providing advertisers with a direct link to top-tier news publishers. This initiative forms part of Stagwell's broader Future of News program, designed to reshape the way brands engage with their audiences through news...
Continue Reading
Market Overview of Canned Seafood The global canned seafood market, estimated at USD 37.70 billion in 2023, is on an impressive growth trajectory. Forecasts indicate it will reach USD 63.64 billion by the year 2032, supported by a compound annual growth rate (CAGR) of 5.99% from 2024 to 2032. This booming market reflects an increasing consumer interest in sustainable food...
Continue Reading
Introduction to the ROBO SNIFFER In a world where safety and security are paramount, innovation is essential. The ROBO SNIFFER aims to revolutionize how we monitor and protect our environments. Developed by a seasoned Fire Protection Engineer with decades of experience, this mobile security and smoke detection robot is designed to provide advanced surveillance...
Continue Reading